Methadone Market Size & Share, by Form (Oral Solution, Tablets, Intravenous Injections); Application (Pain Treatment, Detoxification, Maintenance Therapy, Addiction Rehabilitation); End-user (Hospital, Rehab Centers, Drug Stores, Research Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3793
  • Published Date: Apr 26, 2023
  • Report Format: PDF, PPT

Companies Dominating the Methadone Landscape

top-features-companies
    • Eli Lilly and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sanofi S.A.
    • Hikma Labs Inc.
    • Mallinckrodt Pharmaceuticals
    • Siegfried Holding AG
    • Johnson Matthey
    • Gilead Sciences, Inc.
    • BioControl Medical
    • Tianjin Central Pharmaceutical Industry Co., Ltd.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Novartis AG will present more than 150 abstracts that highlight the outcomes of research efforts to target disease pathways. These abstracts include updated data in ALK+ non-small cell lung cancer and the first-ever presentations of key data in polycythemia vera, multiple myeloma (blood), and locally advanced or metastatic basal cell carcinoma (skin).
  • Siegfried Holding AG inaugurates a state-of-the-art Development Center for Drug Products in Barcelona, including dedicated facilities for highly potent Drug Products.  The Development Center provides a wide range of development services and flexible pilot capacities, strengthening Siegfried's global Drug Products network. The opening concludes the successful integration of the two pharmaceutical manufacturing sites in Spain which were acquired by Siegfried beginning of 2021.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3793
  • Published Date: Apr 26, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing demand for methadone rehabilitation of heroin addicts is the major factor driving the growth of the methadone market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2035.

Circulation of methadone and its addictive nature are the few factors likely to hamper market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., Novartis AG, and many more.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by form, end user, region, and by application.

The rehab center sub-segment from the vehicle type segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying